Health authorities in the UAE have issued an urgent advisory regarding a counterfeit batch of Botox, specifically identifying batch number C7048C4. The Emirates Drug Establishment confirmed that these illicit products did not enter the country through official, regulated channels. Officials have mandated that all healthcare providers, pharmacies, and medical facilities immediately cease the use, distribution, and sale of this specific batch to prevent potential harm to patients.

Using unverified medical products carries significant health risks, as these counterfeit versions lack the rigorous safety and quality standards required for clinical use. Such products can trigger severe allergic reactions, unexpected side effects, and other long-term complications. The authorities are calling on the public and medical professionals to remain vigilant and report any suspicious stock to the National Medical Products Vigilance Department. Patients who have recently undergone Botox procedures and are experiencing any abnormal symptoms are encouraged to contact their healthcare provider immediately for an evaluation.